Lactobacillus rhamnosus Lcr35(R) as an effective treatment for preventing Candida albicans infection in preclinical models: first mechanistical insights
C. Poupet, T. Saraoui, P. Veisseire, M. Bonnet, C. Dausset, M. Gachinat, O. Camares, C. Chassard, A. Nivoliez, S. Bornes
This study shows that Lactobacillus rhamnosus Lcr35(R) prevents Candida albicans infection in vitro and in vivo by inhibiting pathogen growth, adhesion, and virulence while activating host immune pathways.
bioRxiv · Apr 18, 2019Microbiology